CardioKinetix Inc. Announces Positive Clinical Data Showing Consistent Compelling Positive Results for Patients Treated With Minimally Invasive Structural Heart Device for Heart Failure
5/22/2013 11:13:09 AM
PARIS & MENLO PARK, Calif.--(BUSINESS WIRE)--CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute® Ventricular Partitioning Device. Six-month clinical results from 91 U.S. and European patients with ischemic heart failure were presented at the 2013 EuroPCR Conference in Paris by Dr. Martyn Thomas, M.D., chairman of Cardiology at St. Thomas Hospital in London, England.
Help employers find you! Check out all the jobs and post your resume.
comments powered by